Monograph
J07BC02 - Hepatitis A, Inactivated, Whole Virus |
Propably not porphyrinogenic |
PNP |
Rationale
Based on the pharmacokinetics of the hepatitis A, inactivated, whole virus vaccine, there are no conceivable porphyrinogenic effects.
Chemical description
Inactivated hepatitis A virus.
Therapeutic characteristics
The vaccine is indicated for the active immunization of adults and children over the age of 1against hepatitis A. It is administered by a single intramuscular injection. A booster dose is recommended after 6-12 months in order to obtain more persistent immunity.
Metabolism and pharmacokinetics
The hepatitis vaccine is not metabolized by the cytochrome P450 system.
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Government bodies | |
| 1. | Norwegian Institute of Public Health. Vaksinasjonsveilederen. www.fhi.no (updated 13.10.2015).
|
|
| * | Summary of Product Characteristics | |
| 2. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Havrix.
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Avaxim · Havrix · Vaqta 
Avaxim · Havrix · Vaqta 
Avaxim · Havrix · Vaqta Unidades · VAQTA UNIDADES/0,5ml · VAQTA UNIDADES/1 ml · VAQTA UNIDADES/1ml 
Avaxim · Havrix 
Avaxim · Avaxim vaccine · Epaxal Berna · Epaxal vaccine · Havrix · Havrix Junior Monodose vaccine · Havrix Monodose vaccine · Vaqta · VAQTA Paediatric vaccine · VAQTA vaccine 
Avaxim · Havrix · Vaqta 
Havrix 
Avaxim · Havrix · Vaqta 
Avaxim · Havrix · Vaqta 
Havrix 
Avaxim · Havrix · Vaqta 
Avaxim · Havrix 
Avaxim
© NAPOS 2025